It's been an action-packed week with announcements of a number of FDA approvals, a couple of Big Pharma names failing in late-stage trials, and two acquisitions. Let's take a look at the pharma stocks and upcoming events to keep an ear out for in the coming week.
Original Article: An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYAD.)